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Multiple eruptive dermatoﬁbromas are a rare presentation of dermatoﬁbroma and have been associated
with altered immunity. A rare case of multiple eruptive myxoid dermatoﬁbromas (MEMDFs), charac-
terized by marked stromal mucin deposition, is reported herein; additionally, an in-depth discussion on
the implication of altered immunity is presented. Because MEMDFs can be an initial manifestation of
systemic lupus erythematosus, it is necessary for dermatologists to perform a skin biopsy for patho-
logical diagnosis and a comprehensive survey for autoimmunity, infectious diseases, especially human
immunodeﬁciency virus infection, hematologic diseases, and malignancies, or other immunodeﬁciency
conditions when the patient is diagnosed with MEMDFs.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Dermatoﬁbromas are common benign ﬁbrohistiocytic lesions that
are most often solitary and occur on the legs of middle-aged
women.1 Multiple eruptive dermatoﬁbromas (MEDFs) are a rare
presentation of dermatoﬁbroma and have been associated with
altered immunity, such as in the case of human immunodeﬁciency
virus (HIV) infection and autoimmune diseases treated with
immunosuppressive therapy.2 Myxoid dermatoﬁbroma, character-
ized by marked stromal mucin deposition, is an extremely rare
variant of dermatoﬁbroma, found only in 0.4% of all dermatoﬁ-
bromas.3 Only one single case of multiple eruptive myxoid der-
matoﬁbromas (MEMDFs) in a healthy woman was published in the
literature.4 Herein, we report another rare case of MEMDFs as an
initial manifestation of systemic lupus erythematosus (SLE).Case report
A 51-year-old woman presented with 20 ﬂesh-colored to pinkish
asymptomatic papules that developed within 2 months (Figure 1).
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.from 3 mm to 8 mm. Differential diagnoses included eruptive xan-
thomas, dermatoﬁbromas, neuroﬁbromas, and lymphoproliferative
diseases. A skin biopsy was performed, which showed a dermal
nodule of ﬁbrohistiocytes and thin collagen ﬁbers accompanied by
lymphocytes in a myxoid stroma (Figure 2). Abundant mucin was
demonstrated in the lesionusingAlcian blue stain,with andwithout
hyaluronidase digestion. An immunohistochemical study showed
that the spindle tumor cells were positive for factor XIIIa, CD68,
CD44, and CD163; weakly positive for NK1/C3; and negative for S-
100 protein, CD34, caldesmon, and collagen type IV. Neurogenic and
smooth muscle tumors were excluded. The immunophenotype was
compatible with dermatoﬁbroma. Because the patient hadmultiple
lesions with profound mucin deposits, MEMDFs were diagnosed.
Laboratory investigations indicated leucopenia (leukocyte count
3000/mL), speckled antinuclear antibody pattern (1:160 titer),
hypocomplementemia (C3 at 77.50 mg/dL and C4 at 4.63 mg/dL),
positive antidouble-strand DNA antibody, positive anti-Smith anti-
body (anti-Sm), positive anti-Ro/SSA antibody, and equivocal anti-
La/SSA antibody. Other laboratory ﬁndings, including rapid plasma
reagin andHIV tests, were negative orwithin normal limits.MEMDF
as an initial manifestation of SLE was diagnosed. The patient was
treated with prednisolone and hydroxychloroquine. The number of
skin lesions continued to increase in the 1st month, but started
resolving 3 months later without recurrence.Discussion
A survey of literature for studies on dermatoﬁbromas published be-
tween 1962 and 2014 reveals that only 62 patients were reportedevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1 (A, B) Twenty ﬂesh-colored to pinkish asymptomatic dome-shaped papules were noted on both arms and legs of the patient. (C, D) A skin biopsy was performed on a
pearly, ﬂesh-colored papule on her right forearm.
Figure 2 (A) Histopathology from the lesion on the right forearm showed a slightly polypoid skin with a dermal nodule of ﬁbrohistiocytes and thin collagen ﬁbers in a myxoid
stroma. (hematoxylin and eosin; original magniﬁcation 40). (B) Collagen ﬁbers surrounded by interlacing fascicles of spindled cells with abundant mucin deposition in the stroma
were seen at higher magniﬁcation (hematoxylin and eosin; original magniﬁcation 400).
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middle-aged female patients [39/62 (62.9%); mean age 38.3 years] is
worth noting. Most patients had associated diseases [50/62 (80.7%)],
and among them nearly half had autoimmune diseases [24/50
(48.0%)] with SLE predominance [18/24 (75.0%)]. Sj€ogren syndrome,
dermatomyositis, Graves disease, myasthenia gravis, rheumatoid
arthritis, and pemphigus vulgaris were also reported as the autoim-
mune diseases. Most [22/24 (91.7%)]MEDFs patients associatedwith
an autoimmune disease were women, and all [18/18 (100%)] MEDFs
patientswith SLEwere adultwomen.Other associated diseaseswere
HIV infection, hematologic diseases (e.g., chronic myelogenous leu-
kemia, myelodysplastic syndrome, and multiple immunoglobulin A
myelomas),metabolic diseases (e.g., diabetes, hypertriglyceridemia),
and inﬂammatory diseases (atopic dermatitis, psoriasis, and
sarcoidosis), amongothers; furthermore, it is was also reported to be
associatedwith kidney transplantation, and pregnancy. Ten of the 11
MEDFs patients with HIV infection were male and the only patient
having both HIV infection and SLE was a female.Survey ﬁndings indicate that MEDFs occur mostly before or
concurrently with the diagnosis of other associated diseases or
altered immune status, and exacerbate or improve after treatment
with immunosuppressants. Previous reports suggested that both
the diseases and their treatments, such as treatment with cortico-
steroids, cyclophosphamide, azathioprine, cyclosporine A, metho-
trexate, hydroxychloroquine, monoclonal antibodies, and other
chemotherapeutic agents, are related to the occurrence of MEDFs.2
The development of MEDFs after the commencement of highly
active antiretroviral therapy, possibly relating the condition to the
syndrome of immune restoration, was also reported.5 Immuno-
suppression, autoimmunity, and immune restitution may all pre-
dispose to the development of MEDFs.
The pathogenesis of dermatoﬁbroma remains unclear. It is
controversial whether it is a true neoplasm or a reactive hyper-
plasia.6 An abortive immunoreactive process of inﬁltrating T cells
responding to an unknown antigen presented by dermal dendritic
cells was postulated.7 Increased dermal mucin deposition is a
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inﬂammatory processes.8 Because of the rarity of MEMDFs cases,
it is unclear whether MEMDFs is a speciﬁc reactive or neoplastic
process or just a coincidental ﬁnding with mucin deposition, and
this needs further investigations.
Dermatologists must be aware that MEDFs may imply altered
immunity and MEMDFs might be an initial manifestation of SLE. A
skin biopsy for pathological diagnosis and a comprehensive survey
for autoimmunity, infectious diseases, especially HIV infection,
hematologic diseases and malignancies, or other immunodeﬁ-
ciency conditions are necessary when MEMDFs are diagnosed.
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